Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%
Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
Randomized phase II trial aims to compare surgery with or without adjuvant chemotherapy in
treating patients who are pathologically diagnosed as stage I lung adenocarcinoma with
micropapillary component no less than 20%.